The health care industry is increasingly relying on AI – in responding to patient queries, for example – and a new Cornell study shows how decision-makers can use real-world data to build sustainability into new systems.
Cornell researchers have identified the signaling mechanism that triggers steroid-induced glaucoma by creating a 3D “eye-on-a-chip” platform that mimics the flow of ocular fluids.
Cornell researchers have identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes typhoid fever.
The study found heart failure rates were higher in flooded areas, especially in New Jersey, and that the risk persisted for four to five years – not just weeks or months – after the storm.
COVID-19 prevention methods such as masking and social distancing also suppressed the circulation of common respiratory diseases, leaving young children lacking immunity to pathogens they otherwise would have been exposed to, a new study reveals.
A Cornell-led collaboration devised a potentially low-cost method for producing antibodies for therapeutic treatments: bioengineered bacteria with an overlooked enzyme that can help monoclonal antibodies boost their immune defenses.